Home › NDC Lookup › RxCUI directory › RxCUI 1428927

Triprolidine hydrochloride 0.625 MG/ML Oral Solution — RxCUI 1428927

RxNorm drug concept · Semantic clinical drug
RxCUI 1428927 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1428927
Official nameTriprolidine hydrochloride 0.625 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astriprolidine hydrochloride 1.25 MG per 2 ML Oral Solution; triprolidine HCl 0.625 MG in 1 mL Oral Solution; triprolidine hydrochloride 0.625 MG per 1 ML Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)15,849 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triprolidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Triprolidine helps relieve the common, uncomfortable symptoms of hay fever and other upper respiratory allergies — things like a runny nose, sneezing, itchy or watery eyes, and itc...
  • Yes, drowsiness is a real possibility with triprolidine, and it's something to take seriously. Avoid driving, operating machinery, or doing anything that needs sharp focus until yo...
  • For children under 6 years old, you should check with a doctor before giving any triprolidine product. The labels for these products don't include dosing for that age group without...
  • Yes — if you have emphysema, chronic bronchitis, glaucoma, or trouble urinating due to an enlarged prostate, you should not take triprolidine without talking to a doctor first. The...
📖 Read our full Triprolidine guide →

🕸️ Concept Web — How Triprolidine hydrochloride 0.625 MG/ML Oral Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Triprolidine hydrochloride 0.625 MG/ML Oral Solution RxCUI 1428927

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Triprolidine 10849
    • Triprolidine hydrochloride 71534
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pediaclear Childrens 2179642
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Triprolidine Oral Solution 376317
    • Triprolidine hydrochloride Oral Solution 2647555
    • Triprolidine Oral Liquid Product 1159349
    • Triprolidine Oral Product 1159350
    • Triprolidine hydrochloride Oral Liquid Product 2659962
    • Triprolidine hydrochloride Oral Product 2661554
    • Triprolidine Oral Solution [Pediaclear Childrens] 2179644
    • Triprolidine hydrochloride Oral Solution [Pediaclear Childrens] 2658680
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Triprolidine hydrochloride 0.625 MG/ML SCDC · 1428926
  • Triprolidine Oral Solution SCDF · 376317
  • Triprolidine hydrochloride Oral Solution SCDFP · 2647555
  • Triprolidine Oral Liquid Product SCDG · 1159349
  • Triprolidine Oral Product SCDG · 1159350
  • Triprolidine hydrochloride Oral Liquid Product SCDGP · 2659962
  • Triprolidine hydrochloride Oral Product SCDGP · 2661554

Brand-Name Concepts

  • Triprolidine hydrochloride 0.625 MG/ML Oral Solution [Pediaclear Childrens] SBD · 2179647
  • Triprolidine hydrochloride 0.625 MG/ML [Pediaclear Childrens] SBDC · 2179643
  • Triprolidine Oral Solution [Pediaclear Childrens] SBDF · 2179644
  • Triprolidine hydrochloride Oral Solution [Pediaclear Childrens] SBDFP · 2658680
  • Pediaclear Childrens Oral Liquid Product SBDG · 2179645
  • Pediaclear Childrens Oral Product SBDG · 2179646
  • Pediaclear Childrens BN · 2179642

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1428927 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58809-0651-50 50 mL in 1 BOTTLE, DROPPER (58809-651-50) Childrens PediaClear PD GM Pharmaceuticals, INC 2019-07-01
Observed labelers: GM Pharmaceuticals, INC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.